Latest Articles

CRISPR is a gene editing technique that promises to revolutionize genetic engineering, but already is raising ethical, business, and legal issues. This article provides a snapshot of CRISPR technology and patent application filings. If you are interested in more information, please download a digital copy of our web conference on “Navigating the CRISPR Patent Landscape and Business Impact” or contact any of the authors.…
CRISPR is a gene editing technique that promises to revolutionize genetic engineering, but already is raising ethical, business, and legal issues. This article provides a snapshot of CRISPR technology and patent application filings. If you are interested in more information, please download a digital copy of our web conference on “Navigating the CRISPR Patent Landscape and Business Impact” or contact any of the authors.…
The Chinese government has been in the process of modernizing its telemedicine law and policy and associated infrastructure for nearly 2 years now, to support broad, domestic application of telemedicine. We outline one of the most recent developments below. On June 21, 2016, the State Council of China, China’s highest executive body, issued Guiding Opinions on Promoting and Regulating Healthcare Big-Data Applications and Developments [国务院办公厅关于促进和规范健康医疗大数据应用发展的指导意见] (“Guidance”), which provides a roadmap of what China…
Many patent owners have not yet had to defend against an inter partes review (IPR), but the popularity of this proceeding increases the chances that they will encounter it down the road if they have not already faced one. This article explores IPR proactive defense measures that may be useful for patent owners to deploy in advance of facing an IPR.…
Telemedicine continues to attract international attention, with China on track to become one of the largest telemedicine markets in the world. Just a year after the National Health and Family Planning Commission of the People’s Republic of China (NHFPC) began promoting the development of a national telemedicine network in China, multiple telemedicine pilots are already being implemented at the provincial level. This will strengthen the foundation at local levels in China for the expansion…
As U.S. hospitals and health care providers continue to explore China’s market for international health care business opportunities, including telemedicine, they often consider providing services or products to consumers through partnerships with Chinese medical institutions and other entities. U.S. hospitals and health care providers should know how their services or products are being advertised and promoted by their China partners, particularly in light of proposed China rules regarding medical advertisements. Being aware of and…
Manufacturers with operations, employees, and/or customers in China must be aware of a long list of China-specific data-flow and content restrictions. Data-flow restrictions in particular affect manufacturers employing or launching mobile apps and other IT initiatives, both internal and external. Manufacturers must be very sensitive to China’s rules and guidelines restricting data flow, as these can affect plans for data storage, transmission and even analysis. American industry associations have called upon China to openly discuss
U.S. health care providers, device manufacturers, lab managers, health information technology and telemedicine/telehealth project investors, and other industry members involved in projects in China, need to be aware of a long and growing list of China-specific data-flow and content restrictions. These restrictions are increasingly concerning in light of the health care industry’s growing use of cloud technology and need for financial and other systems that protect medical record, insurance data and other sensitive information, but…
This post is the third in Foley’s blog series, “Realizing the Potential of Telemedicine in China,” meant to address top issues facing U.S. companies looking to enter the Chinese telemedicine market. We continue to work with more and more U.S.-based providers to create international telemedicine programs, and without question China remains the region of hottest interest. Hospitals and health systems, academic medical centers, physician enterprises and innovative entrepreneurs continue to look to China for new…
This post is the second in Foley’s blog series, “Realizing the Potential of Telemedicine in China,” meant to address top issues facing U.S. companies looking to enter the Chinese telemedicine market. At a Glance • Meeting U.S. laws on medical record privacy and security is not sufficient to cover a company expanding into China; medical records must meet Chinese requirements as well • EHR cloud storage standards differ in China; U.S. hospitals and providers…